Drug intelligence / Profile preview

Haelan 951

Development stage
Unknown
Lead developer
Haelan Products
Administration
Oral
01

Overview

Haelan 951 is a fermented soy beverage developed by Haelan Products and studied by the M.D. Anderson Cancer Center for the management of cancer-associated anorexia and cachexia. Classified as a nutritional supplement or nutraceutical, it is produced through a specialized fermentation process that concentrates the nutrients of approximately 25 pounds of soybeans into a single 8-ounce bottle. The product contains a complex mixture of active ingredients, including high concentrations of soy isoflavones (genistein, daidzein, and glycitein), soy proteins, protease inhibitors, saponins, phytosterols, and essential minerals like selenium and zinc. Its primary biological mechanism involves the inhibition of nuclear factor-kappa B (NF-kB) by isoflavones, which is thought to modulate inflammatory pathways that contribute to weight loss and appetite suppression in cancer patients.

Brand names
Haelan 951Haelan951Haelan-951Haelan
Other names
fermented soy beverage
02

Targets

NF-κB

Beyond the preview

Go deeper on Haelan 951.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haelan 951.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call